Beta-cell replacement either by pancreatic organ or islet cell transplantation is the only treatment to achieve an insulin-independent, normoglycemic state and to avoid hypoglycemic episodes in patients with type 1 diabetes mellitus. This article will review the state-of-the-art in clinical islet cell transplantation at the dawn of the new millennium and will provide an outlook on the basis of extended personal experience.
No takes yet. Share an insight, caveat, or question.
Bretzel et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: